Castle Biosciences (CSTL) news
Recent news
Castle Biosciences, - Opens new laboratory and office facility in Scottsdale, Arizona
Castle Biosciences has announced the opening of a new laboratory and office facility in Scottsdale, Arizona. The expansion is part of the company’s strategy to enhance its operational capacity and support ongoing research and development efforts. The new location is expected to accommodate…
AInvest Wire · Sep 22, 2026SCIBase receives additional order from Castle Biosciences, advancing the collaboration
AInvest Wire · Sep 8, 2026Castle Biosciences to begin Nasdaq Texas listing today under CSTL
AInvest Wire · Aug 17, 2026Castle Biosciences approved for dual listing on Nasdaq Texas
Castle Biosciences, Inc. (Nasdaq: CSTL) has been approved for a dual listing of its common stock on Nasdaq Texas, LLC, effective August 17, 2026. The company's common stock, which is already listed on The Nasdaq Global Market, will now also trade on Nasdaq Texas under the same ticker symbol "CSTL".…
AInvest Wire · Aug 17, 2026Castle Biosciences Q2 pretax profit USD -1.69 million
Castle Biosciences (Nasdaq: CSTL) reported a pretax loss of USD -1.69 million for the second quarter of 2025, reflecting ongoing financial challenges in its operations during the period. The company, which specializes in precision diagnostics for dermatologic and gastroenterological diseases,…
AInvest Wire · Jul 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.